PT141 10mg

PT-141 | Bremelanotide | 10mg

PT-141 sold as 10 mg lyophilised powder.

PT-141 is a peptide that has been extensively studied for its effects on sexual function and arousal. Research indicates that it influences libido, sexual response, and related neurological pathways. This peptide is a synthetic analog derived from Melanotan II, but it functions through a distinct mechanism. One of its primary mechanisms of action involves the activation of melanocortin receptors, particularly the MC3R and MC4R subtypes, which are involved in regulating sexual arousal.

By binding to melanocortin receptors in the central nervous system, PT-141 influences sexual arousal pathways directly within the brain, rather than acting on the vascular system. It operates differently from other compounds studied in this area, as research suggests, since its effects originate centrally rather than through changes in blood flow. This central mechanism is one of the characteristics that distinguishes it as a subject of ongoing scientific investigation.

The molecule bremelanotide is FDA-approved as the prescription medication Vyleesi, indicated for hypoactive sexual desire disorder in premenopausal women. This product is supplied as a research-use preparation.

Bacteriostatic water is not included.